l-Arginine is related to endothelium-dependent vasodilation in resistance and conduit arteries in divergent ways-The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study

Atherosclerosis

Volumn 203, Issue 2, 2009, Pages 544-549

  Lind, Lars ^a   Larsson, Anders ^a   Teerlink, Tom ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arginine; Asymmetric dimethylarginine; Endothelium; Vasodilation

Indexed keywords

ACETYLCHOLINE; ARGININE; N(G),N(G) DIMETHYLARGININE;

AGED; ARTERY; ARTERY DIAMETER; ARTERY DILATATION; ARTERY RESISTANCE; ARTICLE; BLOOD FLOW; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONDUIT ARTERY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW MEASUREMENT; FOREARM; GENDER; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; PULSE WAVE; VASCULARIZATION;

AGED; ARGININE; ARTERIES; ENDOTHELIUM; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FEMALE; HUMANS; LINEAR MODELS; MALE; NITRIC OXIDE; PROSPECTIVE STUDIES; VASODILATION; VASODILATOR AGENTS;

EID: 62649173609     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.07.016     Document Type: Article

References (27)

1. Moncada S., and Higgs E.A. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147 (2006) S193-201
2. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575
3. Siroen M.P., Teerlink T., Nijveldt R.J., et al. The clinical significance of asymmetric dimethylarginine. Annu Rev Nutr 26 (2006) 203-228
4. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
5. Gokce N., Keaney Jr. J.F., Hunter L.M., et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105 (2002) 1567-1572
6. Perticone F., Ceravolo R., Pujia A., et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104 (2001) 191-196
7. Lind L., Fors N., Hall J., Marttala K., and Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler Thromb Vasc Biol 25 (2005) 2368-2375
8. Takiuchi S., Fujii H., Kamide K., et al. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients. Am J Hypertens 17 (2004) 802-808
9. Perticone F., Sciacqua A., Maio R., et al. Asymmetric dimethylarginine, l-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46 (2005) 518-523
10. Mittermayer F., Schaller G., Pleiner J., et al. Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patients. J Am Soc Nephrol 16 (2005) 1832-1838
11. Maas R., Quitzau K., Schwedhelm E., et al. Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia. Atherosclerosis 191 (2007) 211-219
12. Böger R.H., Bode-Böger S.M., Szuba A., et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation 98 (1998) 1842-1847
13. Stühlinger M.C., Oka R.K., Graf E.E., et al. Endothelial dysfunction induced by hyperhomocyst(e)inemia. Role of asymmetric dimethylarginine. Circulation 108 (2003) 933-938
14. Yilmaz M.I., Saglam M., Caglar K., et al. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 47 (2006) 42-50
15. Ardigo D., Stuehlinger M., Franzini L., et al. ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk. Eur J Clin Invest 37 (2007) 263-269
16. Juonala M., Viikari J.S., Alfthan G., et al. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the Cardiovascular Risk in Young Finns Study. Circulation 116 (2007) 1367-1373
17. Levey A.S., Greene T., Kusek J.W., and Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A
18. Lind L., Sarabi M., and Millgård J. Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm. Clin Physiol 18 (1998) 81-87
19. Lind L., Hall J., Larsson A., et al. Evaluation of endothelium-dependent vasodilation in the human peripheral circulation. Clin Physiol 20 (2000) 440-448
20. Lind L., Pettersson K., and Johansson K. Analysis of endothelium-dependent vasodilation by use of the radial artery pulse wave obtained by applanation tonometry. Clin Physiol Funct Imaging 23 (2003) 50-57
21. Teerlink T., Nijveldt R.J., de Jong S., and van Leeuwen P.A. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303 (2002) 131-137
22. de Jong S., and Teerlink T. Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal Biochem 353 (2006) 287-289
23. Dawes M., Chowienczyk P.J., and Ritter J.M. Quantitative aspects of the inhibition by N(G)-monomethyl-l-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature. Br J Pharmacol 134 (2001) 939-944
24. Kielstein J.T., Bode-Böger S.M., Frölich J.C., et al. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107 (2003) 1891-1895
25. Wu G., and Morris Jr. S.M. Arginine metabolism: nitric oxide and beyond. Biochem J 336 (1998) 1-17
26. Huynh N.N., and Chin-Dusting J. Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharmacol Physiol 33 (2006) 1-8
27. Wilson A.M., Harada R., Nair N., Balasubramanian N., and Cooke J.P. l-Arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation 116 (2007) 188-195